Page 2 of GlobalData

mRNA vaccines lead next-generation efforts to combat H5N1 amid global outbreaks: GlobalData

According to GlobalData, while the majority of the 22 vaccine candidates currently in development rely on traditional approaches, mRNA vaccines…

September 23, 2024 18:01 IST

Knee replacement innovations to reshape competitive landscape of orthopedic market, says GlobalData

According to GlobalData, the global knee replacement market is projected to register a compound annual growth rate (CAGR) of 3.16%…

September 21, 2024 18:43 IST

Global migraine market to reach $16.4 billion in 7 major markets by 2033, forecasts GlobalData

Many countries, particularly in Europe, have stricter reimbursement rules than the guidelines recommend, meaning that access will be an ongoing…

September 9, 2024 17:56 IST

The decision to cap inhaler prices comes in response to growing concerns over the prohibitive costs of asthma medications.

Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base: GlobalData

With pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca participating in this initiative, the policy has garnered widespread support and…

July 1, 2024 15:41 IST

Biopharmaceutical M&A deals surge by 71 percent YoY during Q1 2024: GlobalData

Immunology-focused M&As had the largest growth in deal activity compared to Q1 2023, with a 314% surge in deal value…

May 14, 2024 16:03 IST

Doctors lack consensus on patient choice between branded and generic drugs: GlobalData

To address this situation, it is essential to foster open communication and collaboration between physicians and patients, GlobalData stated.

April 19, 2024 12:06 IST

Biomarkers becoming important for approval of amyotrophic lateral sclerosis therapies: GlobalData

According to GlobalData’s Drugs Database, the ALS pipeline consists of 51 candidates in various stages of development (Phase I–III) across…

March 19, 2024 10:27 IST

GLP1 agonists set to become the best-selling drugs in 2024, says GlobalData

Leading the charge in the GLP1 market are five key drugs: Mounjaro, Ozempic, Wegovy, Cagrisema, and Rybelsus, which are forecast…

March 19, 2024 10:22 IST

New study reveals South-Asia specific mutations associated with Parkinson's disease among younger population

Cell therapies show promise for addressing Parkinson’s disease non-motor symptoms

Bemdaneprocel was well tolerated across the cohorts with only one severe adverse event reported; a seizure event believed to have…

March 19, 2024 10:00 IST

Female contraceptives, female contraceptive market, GlobalData, healthcare news,

Female contraceptives market still requires therapeutics with better safety profiles: GlobalData

Educational interventions can help increase knowledge of available contraceptive methods, enabling individuals to make informed decisions and use contraception more…

January 12, 2024 17:03 IST

Globaldata, Gaucher disease, major markets, healthcare news, pharma news,

Gaucher disease market to reach $1.3 billion across 7 major markets in 2032, forecasts GlobalData

The launch of venglustat malate will be the main drivers of steady market growth over the forecast period.

December 28, 2023 08:00 IST

Verve, gene therapy, cardiovascular diseases, healthcare news,

Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in cardiovascular disease: GlobalData

The VERVE-101 clinical trial shows that this therapeutic approach can also be used to target genes associated with cardiovascular disease…

November 16, 2023 14:00 IST

Novartis, patent loss, tasigna, healthcare news, pharma news,

Novartis blockbuster drug Tasigna faces sales decline as US patent expiry looms: GlobalData

The US is one of the most important markets for Tasigna, as it contributed 39% of the drug’s total historical…

November 14, 2023 10:00 IST

psoriasis, Imsidolimab, healthcare news, pharma news, GlobalData news,

AnaptysBio’s psoriasis drug pipeline agent poses challenge to Boehringer Ingelheim’s Spevigo: GlobalData

These results of AnaptysBio’s imsidolimab gives potential to the company to establish itself as a future player in the GPP…

November 3, 2023 17:57 IST

Infectious diseases, GlobalData, antifungal resistance, healthcare news, pharma news,

Novel antifungals essential to tackle antifungal resistance, says GlobalData

Incident cases of invasive fungal infections are also expected to escalate in the coming years, in part, due to the…

September 20, 2023 08:00 IST

healthcare revolution, health news, pharma news,

Industry backlash may reshape EU compulsory pharma licensing reform, says GlobalData

According to GlobalData, Both Johnson & Johnson and Pfizer criticized the changes by referencing the positive role of patents in…

August 21, 2023 09:00 IST

Healthcare Global Enterprises, HealthCare Global Q2 results, profit, revenue, EBITDA, international operations, healthcare sector, cancer care, acquisition, margin expansion

Diagnosed incident cases of venous thromboembolism set to reach 1.69 million in 2032, forecasts GlobalData

The US will have the highest number of diagnosed incident cases of VTE across the 7MM with 1,061,000 cases.

July 10, 2023 09:00 IST

Inflation law drives biologic drugs to outpace small molecules in venture financing in US, finds GlobalData

According to the analytics company, this is driven by the enactment of the inflation law in the country to drive…

July 5, 2023 09:00 IST

Related News

Canada work permit, Canada Temporary Foreign Worker Program, Canada TFWP Rules, Canada LMIA process, LMIA process

Canada drops wage assessment under TFWP; Work permits now based on LMIA

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

LIVE: Meesho IPO allotment today – GMP drops 15% from peak; How to check status, key listing detail

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Paramount launches $108.4 billion hostile takeover bid for Warner Bros Discovery

World News8 min ago

Paramount Skydance has launched a hostile bid worth $108.4 billion for Warner Bros Discovery, in an attempt to outbid Netflix and create a media powerhouse. However, Netflix has already secured a $72 billion equity deal for Warner Bros Discovery’s assets.

View all shorts